SEC Form 4 · accession 0001225208-18-004205
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Pierce
Officer — SVP,Pres Urology,Pelvic Health
Period of report
Feb 23, 2018
Accepted (ET)
Feb 26, 2018 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2018 | M | 2,452 | $0.00 | A | 28,101 | D | |
| Common Stock | Feb 23, 2018 | F | 1,090 | $27.20 | D | 27,011 | D | |
| Common StockF1 | Feb 24, 2018 | M | 3,058 | $0.00 | A | 30,069 | D | |
| Common Stock | Feb 24, 2018 | F | 1,360 | $27.20 | D | 28,709 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF1,F2 | — | Feb 23, 2018 | M | 2,452 | D | — | Feb 23, 2020 | Common Stock | 2,452 | 4,906 | D |
| Deferred Stock UnitsF1,F3 | — | Feb 24, 2018 | M | 3,058 | D | — | Feb 24, 2019 | Common Stock | 3,058 | 3,058 | D |
Explanation of responses
- F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
- F3Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.